Bioanalysis & Immunogenicity of Biologics & Biosimilars

Kymos Group offers bioanalytical services for a wide range of biological drugs from preclinical and clinical studies, including innovative proteins, biosimilars, therapeutic peptides and enzymes, biomarkers, monoclonal antibodies, hormones, nucleic acids and other large molecules.

We are a GLP-certified and GCP compliant multinational CRO with broad experience in method transfer, regulatory validations and the development of challenging bioanalytical methods for biological drugs from scratch.

We are equipped with state-of-the-art analytical tools such as ELISA, ECLA, HPLC-MS/MS tryptic digestion and routine work includes drug levels and PK/PD calculations, immunogenicity assays including ADAs’ binding and neutralizing antibodies.